Arrowhead Pharmaceuticals, Inc.Arrowhead Pharmaceuticals, Inc.Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc.

No trades
See on Supercharts
Market capitalization
‪3.06 B‬USD
−2.77USD
‪−205.28 M‬USD
‪240.74 M‬USD
‪117.63 M‬
Beta (1Y)
1.93

About Arrowhead Pharmaceuticals, Inc.

CEO
Christopher Richard Anzalone
Headquarters
Pasadena
Employees (FY)
525
Founded
1989
ISIN
US04280A1007
FIGI
BBG000BRVKH0
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ARWR is 24.01 USD — it has decreased by 2.79% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Arrowhead Pharmaceuticals, Inc. stocks are traded under the ticker ARWR.
Arrowhead Pharmaceuticals, Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Arrowhead Pharmaceuticals, Inc. has a max estimate of 90.00 USD and a min estimate of 28.00 USD.
ARWR earnings for the last quarter are −1.02 USD whereas the estimation was −0.61 USD which accounts for −67.60% surprise. Estimated earnings for the next quarter are −0.80 USD. See more details about Arrowhead Pharmaceuticals, Inc. earnings.
Arrowhead Pharmaceuticals, Inc. revenue for the last quarter amounts to ‪16.09 M‬ USD despite the estimated figure of ‪44.63 M‬ USD. In the next quarter revenue is expected to reach ‪33.87 M‬ USD.
Yes, you can track Arrowhead Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, ARWR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Arrowhead Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
ARWR reached its all-time high on Dec 16, 1993 with the price of 2 924.91 USD, and its all-time low was 1.20 USD and was reached on Dec 21, 2016.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 525.00 employees. See our rating of the largest employees — is Arrowhead Pharmaceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Arrowhead Pharmaceuticals, Inc. EBITDA is ‪−285.35 M‬ USD, and current EBITDA margin is −79.97%. See more stats in Arrowhead Pharmaceuticals, Inc. financial statements.